Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: a study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples